{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:06:03Z","timestamp":1757455563220},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s12664-016-0664-x","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T08:01:15Z","timestamp":1464076875000},"page":"190-194","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["5-year efficacy of entecavir in Indian patients with chronic hepatitis B"],"prefix":"10.1007","volume":"35","author":[{"given":"Gautam","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,24]]},"reference":[{"key":"664_CR1","unstructured":"World Health Organization. Hepatitis B. World Health Organization Fact Sheet No 204 (Updated July 2014) [accessed 2015 Dec 01]. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/ ."},{"key":"664_CR2","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/j.1440-1746.2005.04070.x","volume":"20","author":"A Chowdhury","year":"2005","unstructured":"Chowdhury A, Santra A, Chakravorty A, et al. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. J Gastroenterol Hepatol. 2005;20:1712\u201320.","journal-title":"J Gastroenterol Hepatol"},{"key":"664_CR3","first-page":"733","volume":"23","author":"J Lian","year":"2015","unstructured":"Lian J, Han T, Xiang HL, et al. A randomized controlled trial on 240-week monotherapy with entecavir or adefovir in patients with chronic hepatitis B and cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2015;23:733\u20137.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"664_CR4","doi-asserted-by":"publisher","unstructured":"Tseng KC, Tseng CW, Hsieh TY, et al. Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside\/nucleotide analogues. Hepatol Res. 2015 Sep 30. doi: 10.1111\/hepr.12600 . (Epub ahead of print)","DOI":"10.1111\/hepr.12600"},{"key":"664_CR5","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1007\/s10620-015-3775-9","volume":"60","author":"TL Fong","year":"2015","unstructured":"Fong TL, Tien A, Jo KJ, et al. Durability of hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with entecavir or tenofovir. Dig Dis Sci. 2015;60:3465\u201372.","journal-title":"Dig Dis Sci"},{"key":"664_CR6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.23327","volume":"51","author":"TT Chang","year":"2010","unstructured":"Chang TT, Lai CL, Kew Yoon S, et al. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B. Hepatology. 2010;51:422\u201330.","journal-title":"Hepatology"},{"key":"664_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1586\/17474124.2016.1125781","volume":"10","author":"HW Lee","year":"2016","unstructured":"Lee HW, Park JY, Ahn SH. An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults. Expert Rev Gastroenterol Hepatol. 2016;10:177\u201386.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"664_CR8","first-page":"314","volume":"32","author":"UC Patra","year":"2011","unstructured":"Patra UC. An open label prospective observational study to evaluate the efficacy of entecavir in HBeAg positive treatment na\u00efve chronic hepatitis B patients in a tertiary care center in eastern India. Trop Gastroenterol. 2011;32:314\u20136.","journal-title":"Trop Gastroenterol"},{"key":"664_CR9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12664-015-0576-1","volume":"34","author":"SK Goyal","year":"2015","unstructured":"Goyal SK, Dixit VK, Shukla SK, et al. Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis. Indian J Gastroenterol. 2015;34:286\u201391.","journal-title":"Indian J Gastroenterol"},{"key":"664_CR10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.antiviral.2013.02.012","volume":"98","author":"AM Ismail","year":"2013","unstructured":"Ismail AM, Sharma OP, Kumar MS, et al. Virological response and antiviral resistance mutations in chronic hepatitis B subjects experiencing entecavir therapy: an Indian subcontinent perspective. Antiviral Res. 2013;98:209\u201316.","journal-title":"Antiviral Res"},{"key":"664_CR11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3350\/cmh.2015.21.1.24","volume":"21","author":"HN Choi","year":"2015","unstructured":"Choi HN, Song JE, Lee HC, et al. Efficacy of prolonged entecavir monotherapy in treatment-na\u00efve chronic hepatitis B patients exhibiting a partial virologic response to entecavir. Clin Mol Hepatol. 2015;21:24\u201331.","journal-title":"Clin Mol Hepatol"},{"key":"664_CR12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3906\/sag-1309-78","volume":"45","author":"K\u00c7 Bi\u00e7er","year":"2015","unstructured":"Bi\u00e7er K\u00c7, Ari A, Gen\u00e7 VE, et al. Efficacy of entecavir treatment among chronic hepatitis B nucleos(t)ide-na\u00efve and -experienced patients. Turk J Med Sci. 2015;45:99\u2013104.","journal-title":"Turk J Med Sci"},{"key":"664_CR13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3904\/kjim.2015.30.2.170","volume":"30","author":"YJ Jo","year":"2015","unstructured":"Jo YJ, Kim KA, Lee JS, et al. Long-term virological outcome in chronic hepatitis B patients with a partial virological response to entecavir. Korean J Intern Med. 2015;30:170\u20136.","journal-title":"Korean J Intern Med"},{"key":"664_CR14","doi-asserted-by":"crossref","first-page":"9598","DOI":"10.3748\/wjg.v21.i32.9598","volume":"21","author":"JL Wang","year":"2015","unstructured":"Wang JL, Du XF, Chen SL, et al. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy. World J Gastroenterol. 2015;21:9598\u2013606.","journal-title":"World J Gastroenterol"},{"key":"664_CR15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jmv.24330","volume":"88","author":"JH Park","year":"2016","unstructured":"Park JH, Ahn SJ, Cho HJ, et al. Clinical course of partial virological responders under prolonged entecavir monotherapy in patients with chronic hepatitis B. J Med Virol. 2016;88:252\u20139.","journal-title":"J Med Virol"},{"key":"664_CR16","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1128\/AAC.01017-15","volume":"59","author":"HW Lee","year":"2015","unstructured":"Lee HW, Kwon JC, Oh IS, et al. Prolonged entecavir therapy is not effective for HBeAg seroconversion in treatment-naive chronic hepatitis B patients with a partial virological response. Antimicrob Agents Chemother. 2015;59:5348\u201356.","journal-title":"Antimicrob Agents Chemother"},{"key":"664_CR17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.clinre.2014.09.009","volume":"39","author":"LB Yan","year":"2015","unstructured":"Yan LB, Chen EQ, Bai L, et al. Efficacy of entecavir treatment for up to 96 weeks in nucleoside-naive HBeAg-positive chronic hepatitis B patients with high viral load. Clin Res Hepatol Gastroenterol. 2015;39:366\u201372.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"664_CR18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/jvh.12358","volume":"22","author":"R Idilman","year":"2015","unstructured":"Idilman R, Gunsar F, Koruk M, et al. Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-na\u00efve chronic hepatitis B patients in the real-world setting. J Viral Hepat. 2015;22:504\u201310.","journal-title":"J Viral Hepat"},{"key":"664_CR19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/1471-2334-14-439","volume":"14","author":"HR Sohn","year":"2014","unstructured":"Sohn HR, Min BY, Song JC, et al. Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs. BMC Infect Dis. 2014;14:439.","journal-title":"BMC Infect Dis"},{"key":"664_CR20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bjid.2014.05.016","volume":"18","author":"YW Tan","year":"2014","unstructured":"Tan YW, Ge GH, Sun L, et al. Efficacy of Entecavir therapy in elderly patients with chronic hepatitis B infection. Braz J Infect Dis. 2014;18:691\u20132.","journal-title":"Braz J Infect Dis"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-016-0664-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-016-0664-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-016-0664-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T09:49:50Z","timestamp":1559468990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-016-0664-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1007\/s12664-016-0664-x","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}